Immune disorders in sepsis and their treatment as a significant problem of modern intensive care

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue

Abstract

Despite the great advances in the treatment of sepsis over the past 20 years, sepsis remains the main cause of death in intensive care units. In the context of new possibilities of treating sepsis, a comprehensive response of the immune system to the infection, immunosuppression, in particular, has in recent years gained considerable interest. There is vast evidence pointing to the correlation between comorbid immunosuppression and an increased risk of recurrent infections and death. Immune disorders may impact the clinical course of sepsis. This applies in particular to patients with deteriorated clinical response to infections. They usually suffer from comorbidities and conditions accompanied by immunosuppression. Sepsis disrupts innate and adaptive immunity. The key to diagnose the immune disorders in sepsis and undertake targeted immunomodulatory therapy is to define the right biomarkers and laboratory methods, which permit prompt “bedside” diagnosis. Flow cytometry is a laboratory tool that meets these criteria. Two therapeutic methods are currently being suggested to restore the immune homeostasis of sepsis patients. Excessive inflammatory response may be controlled through extracorporeal blood purification techniques, in large part derived from renal replacement therapy. These are such techniques as high-volume haemofiltration, cascade haemofiltration, plasma exchange, coupled plasma filtration and adsorption, high-absorption membranes, high cut-off membranes. The main task of theses techniques is the selective elimination of middle molecular weight molecules, such as cytokines. Pharmacotherapy with the use of such immunostimulants as interleukin 7, granulocyte-macrophage colony-stimulating factor, interferon gamma, PD-1, PD-L1 and CTLA-4 antagonists, intravenous immunoglobulins may help fight immunosuppressive immune disorders.

Authors and Affiliations

Lidia Łysenko, Patrycja Leśnik, Kamil Nelke, Hanna Gerber

Keywords

Related Articles

Rola stresu oksydacyjnego i oksydazy NADPH w patogenezie miażdżycy

Reaktywne formy tlenu odgrywają istotną rolę w patogenezie miażdżycy. Głównymi mechanizmami odpowiedzialnymi za promiażdżycowe działanie RFT są: oksydacyjna modyfikacja lipoprotein niskiej gęstości, inaktywacja tlenku az...

Krótkoterminowe narażenie na drobny pył zawieszony w powietrzu (PM2,5 i PM10) a ryzyko zaburzeń rytmu serca i udarów mózg

Wyniki badań epidemiologicznych przemawiają za istotnym wpływem zanieczyszczenia powietrza atmosferycznego drobnym pyłem (PM10 i PM2,5) na zdrowie ludzi. Podwyższone stężenie zanieczyszczeń jest związane ze zwiększoną li...

Clinical relevance of chemokine receptor CXCR4

Stromal cell-derived factor-1 (SDF-1/CXCL12) induces intracellular signaling pathways crucial for mobilization, migration, proliferation and survival of many cell types via CXCR4, a chemokine CXC-motif receptor, member...

Charakterystyka naturalnych komórek limfoidalnych (ILC)

Naturalne komórki limfoidalne (innate lymphoid cells, ILC) to nowo opisana rodzina komórek układu odpornościowego, które stanowią element naturalnej odporności, ważnej nie tylko w infekcjach spowodowanych drobnoustrojami...

MAVS protein and its interactions with hepatitis A, B and C viruses

Mitochondrial antiviral signaling protein (MAVS) transmits activation signal of type I interferon (IFN) gene transcription in the molecular intracellular pathway, which depends on the protein encoded by retinoic acid ind...

Download PDF file
  • EP ID EP223501
  • DOI 10.5604/01.3001.0010.3849
  • Views 162
  • Downloads 0

How To Cite

Lidia Łysenko, Patrycja Leśnik, Kamil Nelke, Hanna Gerber (2017). Immune disorders in sepsis and their treatment as a significant problem of modern intensive care. Advances in Hygiene and Experimental Medicine, 71(), 703-712. https://europub.co.uk/articles/-A-223501